Children’s Hospital of Philadelphia is a leading site in the U.S. for world-changing pediatric clinical studies. We have a robust portfolio of active clinical research working with diverse patient populations across a variety of study types and fields. Comprehensive administrative research support ensures researchers at all levels perform highly productive, cost-effective studies that prioritize the patient-family experience. With the help of patients and healthy control participants, we’re finding answers to common, complex conditions and the rarest pediatric diseases. Check out our Research Discovery Finder for more information.
- CHOP Research Institute is one of the nation’s largest recipients of National Institutes of Health funding made available to pediatric hospitals.
- Annually, CHOP Research Institute has between 2,500 and 2,600 investigator-initiated, industry- and federally-sponsored, and foundation-supported IRB active protocols.
- CHOP developed the first two FDA-approved gene therapies. Currently, more than two dozen cell and gene therapy trials are enrolling patients at CHOP.
Sign up to receive information about new studies at CHOP.
Healthy control children are needed to help participate in a study on Immunometabolic Dysregulation.
The goal of this study is to identify unique characteristics in the way kids and teens with Autism Spectrum Disorder (ASD) speak in comparison to typically developing peers.
The Children’s Hospital of Philadelphia is seeking healthy adolescents between the ages of 12-13, who are currently in the 7th grade, to participate in the Sleep and Growth Study 2.
The Division of Rheumatology at CHOP is looking to engage healthy participants for several research studies with the goal of learning more about ways to improve the health and well-being of children and young adults.
Glomerular disease is a major cause of chronic kidney disease associated with substantial morbidity; children and adults with glomerular disease face many threats to bone health.